In a remarkable financial turn, Torrent Pharmaceuticals has disclosed a staggering 30% rise in after-tax profit for the September quarter, reaching ₹591 crore. This impressive growth is attributed to thriving sales in various markets, which escalated their total revenue to ₹3,302 crore.
Fear levels of March 2020? Iran war gives Nifty its worst month since the dreaded Covid crash
Indian equities are suffering their worst month since the Covid crash as the Iran war, $100 crude and heavy FII selling hammer sentiment. Despite the